CytomX Therapeutics
CTMX
$1.89
Share price
-5.50%
Change (1 day)
6.78%
Change (1 year)
Categories
CytomX Therapeutics (CTMX) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.24 B
According to CytomX Therapeutics 's latest financial reports the company's total liabilities are $0.24 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
CytomX Therapeutics - Total liabilities on balance sheet (from 2014 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.24 B | -28.1% |
| 2022-12-31 | $0.34 B | 1.99% |
| 2021-12-31 | $0.33 B | -7.25% |
| 2020-12-31 | $0.36 B | 26.28% |
| 2019-12-31 | $0.29 B | -11.05% |
| 2018-12-31 | $0.32 B | -0.46% |
| 2017-12-31 | $0.32 B | 171.65% |
| 2016-12-31 | $0.12 B | 69.58% |
| 2015-12-31 | $71.14 M | -53.07% |
| 2014-12-31 | $0.15 B | 159.32% |
| 2013-12-31 | $58.46 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $27.91 M | -88.80% | 🇺🇸 USA |